These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5092988)

  • 21. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
    Stepanova-Nikitina GG; Rage KM
    Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases].
    Chrzanowski W
    Pol Tyg Lek; 1969 Jul; 24(27):1057-9. PubMed ID: 4896578
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of mydocalm in the treatment of vascular diseases of the extremities].
    Liubishchev SA
    Klin Med (Mosk); 1967 Jan; 45(1):100-2. PubMed ID: 5613382
    [No Abstract]   [Full Text] [Related]  

  • 25. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peripheral arterial disease--in the field of internal medicine].
    Seki K
    Nihon Rinsho; 1970 Mar; 28 Suppl():854-5. PubMed ID: 5430911
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
    Matsumoto K; Sato K; Tanaka S
    Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

  • 30. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of 1-4-dihydrazinophthalazine on arterial circulation of the limbs in normal and artery disease patients].
    Leoni E
    Gazz Int Med Chir; 1965 Sep; 69(17):1468-74. PubMed ID: 5837540
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of regional artificial circulation in the treatment of obliterating thrombosis of the lower limbs].
    Dutkevich IG; Farshatov MN; Glebov IuI; Dekster BG
    Vestn Khir Im I I Grek; 1966 Jun; 96(6):122-6. PubMed ID: 6000568
    [No Abstract]   [Full Text] [Related]  

  • 33. [New information on obliterative disease of the peripheral vessels and its treatment].
    Masek O
    Vnitr Lek; 1968 Mar; 14(3):301-3. PubMed ID: 5638968
    [No Abstract]   [Full Text] [Related]  

  • 34. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M; Perzanowski A; Myśliwiec M
    Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostacyclin therapy in peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Skawiński S; Głuszko P; Korbut R
    Thromb Res; 1980 Jul 1-15; 19(1-2):191-9. PubMed ID: 6108623
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with bencyclane in internal medicine].
    Braun P; Meskó E; Décsy J
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1405+. PubMed ID: 5536655
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vasculat for intravenous infusion. Tolerance and therapeutic effects].
    Curti PC; Patruno P; Bettini V; Camerota G
    Minerva Cardioangiol; 1973 Sep; 21(9):625-8. PubMed ID: 4147633
    [No Abstract]   [Full Text] [Related]  

  • 40. [Novocain-histamine iontophoresis in the treatment of obliterative artheriosclerosis of the lower limbs].
    Darewicz J; Obrzut A
    Pol Tyg Lek; 1967 Oct; 22(40):1524-6. PubMed ID: 6062536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.